safety of glp-1 receptor agonists Potential Use and GIP/GLP-1 for Respiratory Disorders: Where Are We at? GLP-1 receptor agonists in pediatric

Some reports have suggested a potential increase in suicidality risk associated with semaglutide, though the preponderance of current evidence does not indicate a heightened risk ( 13 , 14 )

Am I a Good Candidate for GLP-1 agonist

Thymus, bone marrow, spleen, mesenteric lymph nodes, brachial/axillary lymph nodes, inguinal lymph nodes, and PBMCs express low levels of Glp1r (29, 33, 34)

In 2021, the sales of Lilly's long-acting GLP-1 receptor agonist product dulaglutide were US$6.472 billion, up 49% from the previous year

The exact cellular localization of the GLP-1R remains equivocal due to the lack of selective antibodies and application of specific anti-GPCR antibodies (113)